Overview

• The Deutsche Gesellschaft für Neurologie proposed de-emphasizing immunological research in ME/CFS and adding psychosomatic approaches, prompting patients on social media to call it a “declaration of war.”
• Immunologist Carmen Scheibenbogen and the Deutsche Gesellschaft für ME/CFS argued that the DGN’s guidance is outdated and could endorse ineffective and harmful treatments.
• Emerging biomedical studies have demonstrated organic disease markers in ME/CFS, including autoantibody-induced postinfectious symptoms in mice and reduced cerebral blood flow in patients.
• Germany’s first specialized ME/CFS and post-infection syndromes station at München-Klinik offers accelerated diagnostics and tailored care to severely affected individuals.
• Developed in partnership with the Technische Universität München, the clinic’s diagnostic and therapy model is slated for rollout to 20 centers nationwide to serve an estimated 650,000 patients.